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-In renal epithelia, vasopressin influences salt and water transport, chiefly via vasopressin V 2 receptors (V2Rs) linked to adenylyl cyclase. A combination of vasopressin-induced effects along several distinct portions of the nephron and collecting duct system may help balance the net effects of antidiuresis in cortex and medulla. Previous studies of the intrarenal distribution of V 2Rs have been inconclusive with respect to segmentand cell-type-related V 2R expression. Our study therefore aimed to present a high-resolution analysis of V 2R mRNA expression in rat, mouse, and human kidney epithelia, supplemented with immunohistochemical data. Cell types of the renal tubule were identified histochemically using specific markers. Pronounced V 2R signal in thick ascending limb (TAL) was corroborated functionally; phosphorylation of Na ϩ -K ϩ -2Cl Ϫ cotransporter type 2 (NKCC2) was established in cultured TAL cells from rabbit and in rats with diabetes insipidus that were treated with the V 2R agonist desmopressin. We found solid expression of V 2R mRNA in medullary TAL (MTAL), macula densa, connecting tubule, and cortical and medullary collecting duct and weaker expression in cortical TAL and distal convoluted tubule in all three species. Additional V 2R immunostaining of kidneys and rabbit TAL cells confirmed our findings. In agreement with strong V 2R expression in MTAL, kidneys from rats with diabetes insipidus and cultured TAL cells revealed sharp, selective increases in NKCC2 phosphorylation upon desmopressin treatment. Macula densa cells constitutively showed strong NKCC2 phosphorylation. Results suggest comparably significant effects of vasopressin-induced V 2R signaling in MTAL and in connecting tubule/collecting duct principal cells across the three species. Strong V 2R expression in macula densa may be related to tubulovascular signal transfer. antidiuretic hormone; thick ascending limb; kidney; sodium-potassiumchloride cotransporter type 2; bumetanide-sensitive cotransporter type 1 ANTIDIURETIC HORMONE [arginine vasopressin (AVP)] serves to regulate body fluid osmolality, blood volume, blood pressure, and vascular tone. In the kidney, two major receptor subtypes [V 1a and V 2 receptors (V 1a R and V 2 R)] have been characterized (22, 24) . V 1a Rs are principally localized in the renal vasculature and glomeruli and mediate the vasopressor effect of AVP (2, 32) . The tubular antidiuretic effect of AVP is mediated by the V 2 R and adenylyl cyclase-dependent cAMP signaling (13, 22) . Since the early work of Morel (25) , sites of V 2 R-mediated AVP action along the nephron have been defined at different levels, such as transport (13, 15, 17) , ligand binding (2, 35, 44) , receptor mRNA expression (9, 32, 47) , and immunohistochemical localization (30, 39) . The collecting duct (CD) is generally considered the principal target for the antidiuretic action of AVP, but available data suggest a role for AVP also in the distal tubule (4, 38, 39) . At both sites, AVP serves to control the renal concentrating mechanism. In the thick ascending limb (TAL), AVP stimulates transepithelial NaCl transport via increased abundance and phosphorylation of Na ϩ -K ϩ -2Cl Ϫ cotransporter type 2 (NKCC2) (10, 11, 14, 15) . In the CD, the main action of AVP is promotion of water reabsorption via the aquaporin type 2 (AQP-2) water channel (13, 17, 28) . Clinically, defective V 2 R function is associated with nephrogenic diabetes insipidus (DI) (22) . Vasopressin agonists and antagonists have been characterized in animal models and studied for use in clinical medicine (10, 11, 43) .
Regarding the prominent functional role of V 2 R-mediated effects of AVP in the kidney, an exact mapping to the renal nephron segments and cell types is of major importance. Previous work has presented information on V 2 R distribution across several mammalian species, but results have in part been inconclusive, and information on cell-type-specific localization of V 2 R biosynthesis is scarce (9, 30, 32, 39, 47) . These studies showed solid V 2 R expression in the CD, with some reference to regional differences in intensity believed to reflect AVPinduced effects on the stimulation/insertion of AQP-2 and urea transporter(s) (4, 28, 36) . Localization of V 2 R was further reported in rat kidney TAL (10, 39) and macula densa (32); binding of oxytocin, which is structurally related to AVP, and expression of oxytocin receptor in macula densa as well (33, 45) support a role for AVP and, possibly, oxytocin in the regulation of glomerular filtration rate (37) . A recent study analyzing V 2 R distribution in mouse and human kidney confirmed V 2 R expression in CD, but not in TAL (9) .
Interest in genetically engineered mice, as well as recent data on the functional significance of AVP-related signaling in the distal tubule, has stimulated us to study in more detail the distribution of the V 2 R in mouse nephron segments with use of nonradioactive in situ hybridization and antibody staining combined with immunostaining by segment-and cell-type-specific markers, and we have analyzed the rat kidney in parallel. Since there is further awareness of the potency to clinically manipulate AVP-related effects in volume disorders and edema, we have extended our approach to the study of the human kidney.
Our results have clearly shown dominant expression of the V 2 R in medullary TAL (MTAL), macula densa, and medullary CD (MCD), intermediate expression in connecting tubule (CNT) and cortical CD (CCD), and low expression in cortical TAL (CTAL) and distal convoluted tubule (DCT) in all three species. To illustrate the functional significance of V 2 R signaling in TAL, we have studied short-term effects of the V 2 R agonist desmopressin (dDAVP) in cultured TAL cells and in Brattleboro rats with central DI by evaluating the intensity and distribution of NKCC2 phosphorylation in the response.
MATERIALS AND METHODS
Animals, tissues, and cells. Adult male Wistar rats (n ϭ 3), Brattleboro rats with DI (Harlan; n ϭ 20), and C57/Bl6 mice (n ϭ 3) were bred in the local animal facility (Charité Berlin) and kept on standard diet and tap water. Animals were anesthetized by an injection of pentobarbital sodium (0.06 mg/g body wt ip). The abdominal cavity was opened, and kidneys were perfused retrogradely through the abdominal aorta using 3% paraformaldehyde (41) . Human kidney samples (n ϭ 3) were derived from tumor nephrectomy; tissues from the healthy parts of the kidneys were immersion fixed in paraformaldehyde. The local council on animal care approved the protocols (permission number G006-2/05 Land Berlin); the standards correspond to the requirements of the American Physiological Society. The human kidneys were from tumor nephrectomy material obtained after written consent of the respective patients from Charité hospital. Tissues were prepared for standard cryostat and paraffin sectioning. Series of 5-m-thick consecutive sections were cut from rat, mouse, and human kidney samples for in situ hybridization and immunohistochemistry. For study of V 2R-mediated changes in expression and phosphorylation status of NKCC2, DI rats were randomly divided into three groups: 1) control, vehicle (intraperitoneal saline)-treated animals (n ϭ 8), 2) animals treated with desmopressin [1-desamino-8-D-Arg vasopressin (dDAVP); 1 ng/g body wt ip] for 30 min (n ϭ 8), and 3) animals treated with vehicle and then subjected to 4 h (from 4 to 8 PM) of water deprivation (n ϭ 4). At the end of the experiments, four DI rats, each from groups 1, 2, and 3, were perfusion fixed for morphological analysis. The remaining DI rats of groups 1 and 2 were killed by an overdose of pentobarbital sodium (Nembutal), the kidneys were removed, and pieces of outer medulla and cortex were dissected. Simian virus 40-transformed rabbit TAL (rbTAL) cells obtained from rabbit kidney medulla were cultured as described elsewhere (48) . Cells were incubated with vehicle or dDAVP (1 ϫ 10 Ϫ7 mol/l; Sigma) in FCS-free culture medium for 30 min. Cells were then harvested and homogenized in sucrose buffer.
In situ hybridization. In situ hybridization was performed as described elsewhere (42) . Briefly, a 584-bp PCR product was amplified from rat kidney cDNA using specific primers for V 2R: 5Ј CAg CAg CCA ggA ggA ACT AC 3Ј (forward) and 5Ј gTg CCA CAA ACA CCA TCA Ag 3Ј (reverse). The amplified fragment was cloned into the pCR4-TOPO vector (Invitrogen) and verified by DNA sequencing. The digoxigenin (DIG)-11-UTP-labeled antisense riboprobe was synthesized by in vitro transcription (DIG RNA labeling kit Sp6/T7, Roche). Since sequence homology was high across species (97% for mouse and 85% for human V 2R), the same probe was used for all species. For in situ hybridization, dewaxed paraffin sections were treated with proteinase K, hybridized for 18 h at 40°C with hybridization mix (2.5 ng mRNA/l), washed, and incubated with sheep anti-DIG alkaline phosphatase-conjugated antibody (DAKO). Signal was generated using 4-nitro blue tetrazolium chloride. For control, a 592-bp nonsense probe was applied in parallel with the antisense probe. Sections were rinsed with PBS, coverslips were applied using PBS-glycerol, and sections were viewed by bright-field microscopy.
Immunohistochemistry. For identification of V 2 mRNA-expressing tubular segments, rabbit polyclonal antibody against V2R was applied (39). For further cell-type-specific identification of the in situ signal, segment-specific antibodies were applied using double labeling or separate labeling of consecutive sections (3, 6, 7 (7); goat anti-AQP-2 antibody (Santa Cruz Biotechnology) for CNT, CCD, and MCD principal cells; and rabbit anti-vacuolar H ϩ -ATPase antibody (Santa Cruz Biotechnology) or rabbit anti-anion exchanger 1 (AE1) (16) antibody for intercalated cells. For separate immunohistochemical labeling, sections were dewaxed and boiled in citrate buffer (pH 6.0) for 5 min. Sections were blocked with 5% milk powder in PBS for 1 h and incubated with primary antibody diluted in 5% milk powder for 1 h at room temperature and then incubated overnight at 4°C. For multiple staining, antibodies were sequentially applied, with a wash step between applications. Next, appropriate secondary fluorescent Cy3-or Cy2-conjugated antibodies (DIANOVA) were applied over a 2-h period. For bright-field V 2R detection, an LSAB-2 System-AP enhancer kit (DakoCytomation) was used. Sections were washed, coverslips were applied with PBS-glycerol, and sections were viewed in a Leica DMRB microscope equipped with a SPOT 32 camera and MetaView 3.6a software (Diagnostic Instruments, Universal Imaging).
Evaluation of phosphorylated NKCC2. For analysis of NKCC2 phosphorylation, rabbit antiserum against phosphorylated NKCC2 (2 NH 2-terminal threonines; see Ref. 11 for peptide sequence) was produced and affinity purified using selection with phosphorylated and nonphosphorylated peptides (Pineda, Berlin, Germany). The affinity-purified antibody against phosphorylated NKCC2 was termed pT2 antibody. Preabsorption tests were performed immunohistochemically using the phosphorylated, as well as the nonphosphorylated, peptides (10-fold excess). The size of phosphorylated NKCC2 as recognized by pT2 antibody was confirmed by Western blot on rat kidney extracts. Specificity was further confirmed by colocalization with 2.1 antibody. Paraffin sections of human kidney were incubated with pT2 antibody and then horseradish peroxidase (HRP) for detection. For double staining, incubation of frozen sections with pT2 antibody was followed by application of 2.1 antibody. HRP-and fluorescent Cy3-coupled secondary antibodies were used for detection.
Western blot. Nuclei were removed by homogenization of excised rat kidney zones and rbTAL cells in sucrose-triethanolamine buffer and centrifugation at 1,000 g for 15 min at 4°C. The supernatants were separated by PAGE [50 g protein/lane, as determined by a bicinchoninic acid protein assay reagent kit (Pierce); 8 -10% gel]. After electrophoretic transfer to PVDF membrane, equity in protein loading and blotting was verified by membrane staining using 0.1% Ponceau red staining. After they were blocked in 5% milk, PVDF membranes were incubated with mouse monoclonal antibody against the COOH-terminal 310 amino acids of NKCC2 (T4 antibody; Developmental Studies Hybridoma Bank, University of Iowa) or pT2 or 2.1 primary antibodies for 1 h at room temperature, incubated overnight at 4°C, and then exposed to HRP-conjugated secondary antibodies for 2 h at room temperature. Immunoreactive bands were detected by chemiluminescence and exposed to X-ray films, and the signals were scanned and densitometrically evaluated. Monoclonal mouse anti-␤-actin antibody (Sigma) was used to normalize all data for expression of the housekeeping gene ␤-actin.
Real-time PCR. Samples of the outer medulla and cortex from DI rats were homogenized, and total RNA was prepared using the RNeasy total RNA kit (Qiagen). Genomic DNA was digested by DNase, and cDNA was synthesized by reverse transcription of 5 g of total RNA (cDNA synthesis kit, Invitrogen). Specific TaqMan gene expression assays for NKCC2 and GAPDH were generated by Applied Biosystems. Amplification was performed using the real-time PCR TaqMan Fast 7500 (Applied Biosystems). Samples were incubated at 94°C for 10 min, and then 45 cycles of 95°C (3 s) and 60°C (30 s) were run. Threshold cycle (Ct) values were set in the linear phase of exponential amplification. The difference between values obtained for NKCC2 and the housekeeping gene GAPDH (⌬Ct) was calculated and compared between treatments and kidney zones.
Analysis of data.
Western blot and real-time PCR results were evaluated using routine parametric descriptive statistics. Groups were compared with two-way ANOVA and t-tests; Bonferroni's correction was used as appropriate. P Ͻ 0.05 was accepted as significant. Values are means Ϯ SD.
RESULTS
We have localized V 2 R mRNA using DIG-labeled antisense probes hybridized to rat, mouse, and human kidney. For additional information, we have used specific antibody to V 2 R. Double-staining techniques or serial sectioning was applied for cell type and segment identification. Results were largely similar among species. Overviews of coronal kidney sections present a clear predominance of V 2 R mRNA expression intensity within the inner stripe of the outer medulla, intermediate strength in the inner medulla, and weaker signals in the outer stripe and the cortical segments. The dominant outer medullary signal was due to the parallel, strong V 2 R expression in MTAL and MCD (Fig. 1) . V 2 R immunoreactive signal essentially paralleled these patterns but revealed less axial heterogeneity in the distal tubule segments.
Cortical vasculature, interstitium, glomeruli, and proximal nephron. Generally, no significant V 2 R mRNA expression was encountered in cortical and medullary vasculature, interstitium, glomeruli, proximal tubules, or thin limbs of the loop of Henle of rat and mouse kidneys. In human kidney, the findings were similar, except for positive signals occasionally found in glomerular parietal epithelium and in the glomerular tuft; the latter, however, was irregular and could not be clearly assigned to a cell type.
Hypothalamic V 2 R mRNA signal. In situ hybridization of rat brain sections was performed for additional confirmation of the specificity of the applied V 2 R riboprobe. Hybridization with the antisense riboprobe produced a specific signal in hypothalamic paraventricular nucleus, as previously characterized functionally (50) , whereas application of the nonsense probe did not produce a signal (Fig. 2, g and h) .
TAL. The TAL, identified by concomitant staining with antibody against NKCC2 or THP, displayed significant V 2 R mRNA expression in the medullary part. The intensity of the inner stripe MTAL signal was strongest (Fig. 1, g-i Specific antibody to V 2 R showed significant staining of MTAL and CTAL segments across species as well (Figs. 3, g and h; and Fig. 4, g and h) . Staining was stronger at the luminal than at the basolateral cell aspect and, particularly, in mice showed somewhat less pronounced axial heterogeneity than the mRNA signal.
DCT, CNT, and CCD. In DCT, identified by concomitant NCC immunostaining, there was significant V 2 R mRNA expression that was moderately stronger than in the preceding CTAL (Fig. 5, a-i; and Fig. 6, a and b) . In the CNT and CCD immunostained by AQP-2, V 2 R mRNA signals were of intermediate intensity (Fig. 1) . CNT segments were identified by their initial transition from DCT2 immunostained for NCC and 11␤-HSD2 or for complementary expression of NCC and AQP-2 (Fig. 5, a-i; and Fig. 6, c and d) . The majority of cortical intercalated cells of CNT and CCD, as identified by parallel H ϩ -ATPase immunostaining, were V 2 R mRNA negative; those with cytosolic/basolateral H ϩ -ATPase staining, likely to correspond to the B phenotype, were generally unstained, whereas those with luminal staining, corresponding to the A phenotype, in part expressed the receptor (Fig. 7, a-d) .
Medullary vasculature, interstitium, thin limbs, and MCD. Medullary vasculature, interstitium, and thin limbs were devoid of V 2 R signal. In the MCD, identified by AQP-2 immunostaining, V 2 R mRNA was markedly expressed in all three species, with the strongest label in human kidney (Fig. 2, c and  d; Fig. 3, c and d; and Fig. 4, c and d) . Medullary type A intercalated cells, identified by basolateral AE1 and apical H ϩ -ATPase immunoreactivity and lack of AQP-2 signal, strongly expressed V 2 R mRNA throughout (Fig. 4, c and d; and Fig. 7, e-l) . V 2 R expression in MCD and CCD was further confirmed by immunohistochemistry, which revealed a strong signal in MCD and a weaker signal in CCD ( Fig. 3g; and Fig.  4, g and h) . The strength of the TAL and CD signals was similar. Medullary intercalated cells, as identified by their morphology, demonstrated strong immunoreactive V 2 R signal throughout (Fig. 4g) .
Effects of AVP on TAL transporter. To verify the significant V 2 R expression in TAL, we studied AVP-dependent activation of the major TAL ion transporter NKCC2 in AVP-deficient DI rats that had been supplemented with dDAVP for 30 min or had been subjected to 4 h of water deprivation. Distribution and abundance of NKCC2, as well as phosphorylated NKCC2, were evaluated using 2.1 and pT2 antibodies, respectively.
In vehicle-treated DI rats, pT2 signal was not detectable in the medulla, whereas scattered pT2-positive TAL segments were observed in the cortex (Fig. 8, a, d, and g; Fig. 9, b and  f) . Macula densa cells showed selectively stronger expression of phosphorylated NKCC2 than adjacent TAL cells (Fig. 9, i  and j) . In low-power magnification, stimulation of DI rats with dDAVP resulted in drastic increases of pT2 signal intensities in CTAL and MTAL compared with vehicle treatment (Fig. 8, a,  b, d, e, g, and h ), whereas water deprivation for 4 h did not significantly affect NKCC2 phosphorylation (Fig. 8, c, f, and i) . Detailed double-staining analysis revealed moderate increases in 2.1 signals, as opposed to more marked increases in pT2 signals, in single CTAL and MTAL profiles, respectively, upon dDAVP treatment (Fig. 9, a-h ). pT2 signals on dDAVPstimulated DI rat kidneys were completely abolished by preincubation with phosphorylated peptide used for immunization during the preabsorption test, whereas application of the nonphosphorylated peptide did not affect the reaction (Fig. 9, k and  l) ; pT2 band specificity was also demonstrated by Western blot (Fig. 9m) . These changes were confirmed by Western blot. Cortical and outer medullary kidney samples of vehicle-or dDAVP-treated DI rats were analyzed. dDAVP treatment resulted in augmented 2.1 signals (ϩ79 Ϯ 11% in cortex and ϩ85 Ϯ 11% in outer medulla, P Ͻ 0.05; Fig. 10, a, b , g, and h), as well as increased pT2 signals (ϩ86 Ϯ 5% in cortex and ϩ198 Ϯ 18% in outer medulla, P Ͻ 0.005; Fig. 10 , c, d, g, and h). Data have been normalized for ␤-actin expression. Quantification of the NKCC2 mRNA in cortical and outer medullary samples did not reveal significant differences between treatments (Fig. 10, i and j) . These results were extended to the study of cultured, immortalized rbTAL cells superfused with vehicle or dDAVP. rbTAL cells express V 2 R (unpublished RT-PCR data and Western blot; Fig. 11a ). Exposure to dDAVP for 30 min resulted in augmented T4 signals (ϩ154 Ϯ 32%, P Ͻ 0.05), as well as increased pT2 signals (ϩ151 Ϯ 37%, P Ͻ 0.05; Fig. 11b ). Data have been normalized for ␤-actin expression.
Application of pT2 antibody to human kidney resulted in substantial CTAL (Fig. 12a) but weak MTAL staining (data not shown). This finding may be related to the functional and endocrine status of the patient's kidney during surgery, possibly preventing medullary activation of NKCC2. By contrast, similar to rodents, human macula densa cells showed a prominent, selective expression of phosphorylated NKCC2 exceeding the level in adjacent CTAL cells (Fig. 12b) .
DISCUSSION
The present study shows the distribution of V 2 R mRNA expression along the nephron in rat, mouse, and human kidneys, complemented with an immunohistochemical approach for detection of the immunoreactive protein. With respect to local AVP signaling in the loop of Henle, V 2 R-dependent phosphorylation of NKCC2, reflecting surface expression of the transporter, was studied in TAL. Expression of V 2 R was established along the major distal epithelia. Medullary and cortical TAL, macula densa and post-macula segment, distal convolutions, CCD and MCD epithelia, and a subset of type A intercalated cells of the three species expressed V 2 R mRNA to distinct degrees of intensity, but with no major interspecies differences. Localization of V 2 R mRNA to these epithelia likely reflected sites of receptor biosynthesis, since parallel immunohistochemistry from this and previous work has provided comparable results, and functional studies have, in part, indicated regional heterogeneity in the renal response to AVP (20, 35) , immunohistochemistry (30, 39) , or in situ hybridization (32) . We have extended the information on overall V 2 R mRNA distribution and its celltype assignment by analyzing mouse and human kidneys.
The major finding of the present study is the localization of significant V 2 R mRNA synthesis to the TAL in the three species, revealing axial heterogeneity with solid expression in the medullary TAL and weak signal along the cortical TAL. This result has previously been obtained in rats at the mRNA (22, 32) and immunoreactive protein (30, 39) levels, although without clear assignment to the particular portions. A heterogeneity in V 2 R mRNA signal intensity between long-and short-looped medullary TAL profiles, as reported earlier in rats (30), was not evident from our results; rather, staining was equally strong in all profiles in the three species. Extending molecular localization of V 2 R to the mouse and human kidney, we have corroborated the significance of a marked medullary presence of the receptor in TAL across representative mammalian species. Concentration of the V 2 R immunoreactive signal at the luminal aspect of TAL across species reflects earlier data from the rat (39) but is at variance with previous demonstration of V 2 R signal located predominantly at the basolateral, and less so at the luminal, aspects (30) . This difference may be antibody based; however, since, in TAL basolateral membrane, folding is extensive whereas the luminal plasma membrane has little surface amplification, the number of receptors per cell side, reflected by the distinct immunoreactivities, may still be comparable. If we consider the apparent presence of V 2 R on both sides of TAL, strong luminal vs. weak basolateral staining may therefore reflect similar receptor densities on each cell pole. Whether this is associated with antagonistic AVP effects of the two locations, as described earlier for the MCD (30), is not clear from the present data.
Our results of a strong V 2 R signal in TAL is at variance with another study reporting no V 2 R mRNA in the TAL of mice and humans (9) . The reason for this discrepancy may be technical, since less-resolving radio-labeled in situ hybridization was used in that study, and it was stated that a diffuse but intensive V 2 R mRNA labeling was prevailing in medulla. Distal epithelia may therefore have escaped identification. In terms of specificity and resolution, our findings of rat hypothalamic paraventricular neurons showing distinct V 2 R staining have demonstrated the viability of our tools.
Functionally, there is solid evidence of a role for V 2 R signaling via cAMP accumulation in medullary ion transport by the TAL, promoting the "single effect" of the countercurrent multiplication as part of the urinary concentrating mechanism (38) . In cortical TAL, AVP may further activate Mg and others explicitly found no V 1a R transcripts in cortical TAL (9) .
Effects of AVP and selective V 2 R agonists and antagonists on TAL have been studied with respect to the gene products involved in transepithelial NaCl transport. Significant changes in the expression or phosphorylation state of key Na ϩ transporters have been reported (10, 11, 18) . In Brattleboro DI rats lacking circulating vasopressin, a decreased steady-state expression of the key ion transporters in TAL was shown to be restored after long-term application of the V 2 R agonist dDAVP (10) . Also, in the short term, dDAVP exerts significant effects in TAL, driving phosphorylation and apical trafficking of the major TAL transporter NKCC2 in mouse kidney (11, 31) . Although this function has earlier been estimated to be relevant only in rodents with their specifically high concentrating ability by some (for review see Ref. 4 ), the high V 2 R expression in the human kidney suggests an analogous, relevant function of AVP in medullary TAL as well. In addition, a parallel, AVPindependent mechanism was postulated on the basis of NKCC2 stimulation in DI rats after short-term water deprivation (23) .
To functionally corroborate our data on V 2 R expression in TAL, we have studied the short-term induction of NKCC2 by AVP in DI rats regionally, determining the abundance of NKCC2 mRNA, whole protein, and NH 2 -terminal threonine phosphorylation. Data were supplemented by the study of our cultured rbTAL cell line, which expresses V 2 R and NKCC2. Western blot V 2 R signal in rbTAL cells showed an expected, dominant band at ϳ50 kDa (39) ; the NKCC2 band generated with the T4 antibody also corresponded to the expected size of 160 kDa (18) . In DI rats, there were clear increases in phosphorylated NKCC2 signal along the entire length of the TAL, with a sharper rise in its medullary portion in DI rats. Corre- Fig. 5 . V2R mRNA distribution in distal convolutions and collecting ducts of rat (a-f) and mouse cortices (g-i). Multiple labeling in consecutive serial sections demonstrates low-to medium-intensity V2R mRNA levels in DCTs (1) identified by Na ϩ -Cl Ϫ cotransporter (NCC), 11␤-hydroxysteroid dehydrogenase (11HSD2), and lack of AQP-2. CNT (2), the onset of which is defined by mutually exclusive NCC vs. AQP-2 signals or by partial overlap of NCC and 11HSD2, representing DCT-to-CNT transitions (horizontal bars), and NCC-negative AQP-2-positive CCD portions (3) showed stronger signals. Original magnification ϫ400.
sponding changes were found in the rbTAL cells. In part, our observations thus mirror earlier data on NKCC2 trafficking in mice (11) . However, at variance with the mouse data, simultaneous increases in the absolute amounts of NKCC2, but not NKCC2 mRNA, were found, possibly reflecting AVP-dependent changes in NKCC2 protein stability or posttranscriptional activation. By contrast, our study failed to reveal an increase of phosphorylated NKCC2 upon water deprivation in the DI rat, which underlines the unique relevance of AVP in TAL transepithelial transport stimulation.
We furthermore found consistent, selectively strong V 2 R expression in macula densa cells in all three species. Previously, radiolabeled in situ signal was reported in rat kidney macula densa (32) , and possible roles of vasopressin V 1 and oxytocin/oxytocin receptor signaling in macula densa function were highlighted (2, 33) . In parallel with V 2 R expression, we found high-level baseline signals of phosphorylated NKCC2 in macula densa across species, suggesting that AVP may influence tubuloglomerular signaling via modulation of NKCC2-dependent transpepithelial transport. This observation may be related to AVP-dependent acute changes in glomerular filtration rate in rat kidney (4, 37) . However, the detection of selectively high phosphorylated NKCC2 immunoreactivity in DI rat macula densa underscores AVP-independent, constitutive activation of the cotransporter at this site.
Our results of V 2 R expression in DCT, CNT, and CCD confirm previous findings in rat (30, 39) and extend the information on the cell-type-specific detail in the three species. Functionally, the presence of V 2 R in DCT, at least in its terminal portion (i.e., DCT2) (3), agrees with published data on increased NCC biosynthesis rate upon long-term dDAVP application in rats (10) . The presence of mineralocorticoid receptors in DCT, CNT, and CCD and the presence of 11␤-HSD2 in DCT2, CNT, and CCD, along with functional data, have underlined local steroid sensitivity of NaCl transport (for review see Refs. 3 and 21). The parallel expression of V 2 R and the epithelial Na ϩ channel (ENaC), the major distal Na ϩ transporter, further emphasizes the manifold hormonal influences on the distal convolutions and collecting system. Functionally, Na ϩ transport and ENaC abundance have been shown to increase under cAMP-dependent vasopressin/V 2 R stimula- tion (8, 10, 26) . A link to the colocalized V 1 R expression (39, 46) and its potentially antagonistic role may be relevant with respect to the cellular control of luminal vs. basolateral transport (for review see Ref. 4) .
The major function of vasopressin relates to the CD, with the hormone acting at physiological concentrations of 10 Ϫ12 M to exert its antidiuretic actions; the V 2 R-dependent effect is coupled to adenylyl cyclase, inducing PKA-mediated phosphorylation of AQP-2 and its translocation to the apical membrane of CD principal cells (for review see Ref. 27) . Our findings of moderate cortical and stronger medullary V 2 R mRNA expression levels across species agree with earlier histochemical (9, 30, 35, 39) and functional (4, 27) data. Less is known about intercalated cells with respect to AVP-induced signaling. This study has clearly defined that a subset of cortical type A intercalated cells and all medullary type A intercalated cells were expressing V 2 R mRNA. Type A intercalated cells may modulate net acid excretion and bicarbonate reabsorption. Acute and chronic effects of vasopressin on acid-base transport have been partially characterized (1, 5, 34) . Type A intercalated cells are dominant in the renal medulla (19) . At this site, they have been shown to express a newly identified basolateral Cl Ϫ /HCO 3 Ϫ exchanger upon dDAVP treatment in DI rats (34), suggesting a possible functional link to V 2 R signaling. Type B intercalated cells, which constitute a significant fraction in the CNT and CCD in rat and mouse kidney, were devoid of V 2 R mRNA. However, long-term dDAVP application in DI rats had marked effects on acid-base transporters also in the type B intercalated cells, possibly owing to the regulatory requirements induced by local solute concentrations (1) .
In summary, a comparative, cell-type-oriented analysis of V 2 R distribution in rat, mouse, and human kidney has been presented at high resolution. Similar expression patterns have been found across these species. Dominant V 2 R expression was observed in medullary TAL and MCD, consistent with the prominent medullary effects of AVP on its major target products, AQP-2 and NKCC2. Functional analysis of AVP-dependent phosphorylation of NKCC2 in the different portions of TAL and cultured rbTAL cells has confirmed the role of V 2 R expression in this segment. Our study provides new insights into the organization of renal volume handling.
